THE PROBLEM

THE PROBLEM

There are 26 FDA approved drugs to treat various sexual dysfunctions for men (41 if you count generics!), but still not a single one for women's most common sexual complaint.  You can see a list of all 26 individually evaluated and approved drugs for men right here, compiled from the FDA's own website26 v 0. That just doesn't make sense all these decades and scientific publications later.

Why do we fast track the approval of drugs like Viagra (1998) for men?  Why do we accept fewer patients in trials for male drugs than we've seen for some for women?  We do we accept risks that we all hear every other Superbowl commercial for men but question what benefit is worth risk for women?  These are the questions that prompted the formation of our coalition.  Sex is a basic human right¹.  If individuals have a medical condition that affects their sexual function, men or women, we believe they deserve access to medical treatment options and the opportunity to make a choice with their healthcare provider on whether or not that treatment is right for them.  The FDA has recognized female sexual dysfunction as one of its 20 priority areas of unmet medical need yet women still wait for a single safe and effective FDA approved treatment option.  Together we must act for the 1 in 10 women, couples and ultimately families affected by this issue.

It's time to even the score when it comes to treatment of women's sexual dysfunction.

Footnotes:

¹(WHO, 2006a, updated 2010)

NOW YOU KNOW

Sign the petition and show your support!

We believe that women have the right to make their own informed choices concerning their sexual health; that gender equality should be the standard in access to sexual dysfunction treatments; and that the approval of safe & effective treatments for low desire should be a priority for the FDA.

Will you join us in telling the FDA that it’s time to give women the options they deserve for the treatment of sexual dysfunction? Sign the petition today & become an advocate for women’s sexual health equity.

Impact

  • How no treatment for HSDD hurts women

    Terry O’Neil, President of NOW

  • The impact of HSDD on women

    Dr. Anita Clayton, M.D.

  • Lack of an HSDD treatment further harms women

    Dr. James Simon, Reproductive Endocrinologist

Equality

  • Treatment Options Must Be Available To All

    Wayne Shields, President of the Association of Reproductive Health Professionals

  • The Unconscious Gender Bias in Women’s Sexual Health Care

    Anita Clayton, M.D.

  • Women’s Sexuality is Just as Important as Men’s

    Terry O’Neil, President of NOW